Elon Musk’s Extensive Drug Use Revealed in 2024

In 2024, Elon Musk’s drug use reportedly escalated well beyond what he publicly admitted. According to a detailed investigation by The New York Times, Musk’s consumption of ketamine was sometimes daily, far exceeding the “small amount” he mentioned in a previous interview. This intense usage reportedly led to health issues such as bladder problems, a known side effect of chronic ketamine use.

Sources close to Musk revealed that he mixed ketamine with a variety of other unspecified drugs, creating a cocktail that affected his mood and behavior. This raised concerns among those who worked with him, noting mood swings and an unusual fixation on expanding his family. These revelations come amid Musk’s high-profile endorsement of Donald Trump’s presidential run and his leadership roles at Tesla and SpaceX.

Despite government-mandated random drug tests at companies like SpaceX, insiders told The Times that Musk was given advanced notice of these tests, potentially allowing him to avoid detection. Additionally, a 2024 Wall Street Journal report highlighted Musk’s use of other substances such as LSD, cocaine, ecstasy, and psychedelic mushrooms, often consumed at private parties with strict confidentiality measures.

These behaviors have not gone unnoticed by Tesla’s board members, some of whom have privately expressed concerns about Musk’s drug use and its impact on company governance. The complex dynamic is intensified by the fact that some board members are close friends who participate in social events involving drugs, complicating oversight and accountability.

Implications for Leadership and Corporate Culture

Musk’s extensive drug use during a critical period raises important questions about the stability and decision-making processes at the helm of major tech companies. When a leader’s personal challenges spill into professional realms, it can affect everything from strategic direction to employee morale and investor confidence. This case highlights the need for robust governance structures and transparent accountability mechanisms in high-stakes industries.

Moreover, the reports underscore the challenges companies face when personal relationships intersect with professional oversight, especially in environments where confidentiality and loyalty can hinder objective evaluation of leadership behavior.

Looking Ahead

As the tech industry continues to evolve rapidly, the Musk story serves as a cautionary tale about the importance of leadership wellness and ethical governance. Stakeholders must remain vigilant and proactive in addressing risks that extend beyond technology and into the personal conduct of those who shape the future.